EMA — authorised 19 May 2021
- Marketing authorisation holder: Gedeon Richter Plc; Estetra SPRL
- Status: approved
EMA authorised Slynd on 19 May 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 19 May 2021.
Gedeon Richter Plc; Estetra SPRL holds the EU marketing authorisation.